Cargando…

CART cell therapy for prostate cancer: status and promise

In recent years, the, chimeric antigen receptor T (CAR-T) cell therapy as an adoptive immunotherapy has received great attention and made great breakthroughs. CAR-T cells show great specificity, targeting, and less major histocompatibility complex restriction in tumor immunotherapy, significantly di...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Haiyuan, Pan, Jun, Guo, Zhicheng, Yang, Chunhua, Mao, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322708/
https://www.ncbi.nlm.nih.gov/pubmed/30655675
http://dx.doi.org/10.2147/OTT.S185556